OTC Markets EXMKT - Delayed Quote USD
Yield10 Bioscience, Inc. (YTENQ)
0.0150
0.0000
(0.00%)
At close: April 30 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
810
60
450
614
799
Operating Expense
13,403
14,477
13,901
12,306
10,408
Operating Income
-12,593
-14,417
-13,451
-11,692
-9,609
Other Income Expense
-109
-38
41
697
-541
Pretax Income
-12,702
-14,455
-13,410
-10,995
-10,150
Tax Provision
38
--
156
36
56
Net Income Common Stockholders
-12,702
-14,455
-13,566
-11,031
-10,206
Diluted NI Available to Com Stockholders
-12,702
-14,455
-13,566
-11,031
-10,206
Basic EPS
-20.14
-43.68
-66.24
-55.92
-103.20
Diluted EPS
-20.14
-43.68
-66.24
-55.92
-103.20
Basic Average Shares
509.5380
331.0950
204.7730
197.1590
98.8860
Diluted Average Shares
509.5380
331.0950
204.7730
197.1590
98.8860
Total Operating Income as Reported
-12,593
-14,417
-13,451
-11,692
-9,609
Total Expenses
13,403
14,477
13,901
12,306
10,408
Net Income from Continuing & Discontinued Operation
-12,702
-14,455
-13,566
-11,031
-10,206
Normalized Income
-12,702
-14,455
-13,566
-11,542
-9,750.4800
EBIT
-12,593
-14,417
-13,451
-11,692
-9,609
EBITDA
-12,322
-14,127
-13,188
-11,472
-9,427
Reconciled Depreciation
271
290
263
220
182
Net Income from Continuing Operation Net Minority Interest
-12,702
-14,455
-13,566
-11,031
-10,206
Total Unusual Items Excluding Goodwill
--
--
--
700
-624
Total Unusual Items
--
--
--
700
-624
Normalized EBITDA
-12,322
-14,127
-13,188
-12,172
-8,803
Tax Rate for Calcs
--
--
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
--
--
--
189
-168.4800
12/31/2020 - 11/10/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade